Photo from wikipedia
The UK’s participation in a new pan-European programme to diagnose and treat complex diseases of rare or low prevalence may be at risk after Brexit, experts have said. Launched on… Click to show full abstract
The UK’s participation in a new pan-European programme to diagnose and treat complex diseases of rare or low prevalence may be at risk after Brexit, experts have said. Launched on 1 March, the European Reference Networks (ERNs) link more than 900 medical teams in centres of excellence across the continent to enable doctors and other healthcare professionals to collaborate and share information on rare diseases. The first wave focuses on 24 disease areas, ranging from bone disorders and haematological diseases …
Keywords:
brexit;
role rare;
raises concern;
concern role;
brexit raises;
rare disease
Journal Title: British Medical Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Medical Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!